Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Precision Medicine in COPD
International Journal of Chronic Obstructive Pulmonary Disease
ISSN: 1178-2005
- View all (3568)
- Volume 19, 2024 (83)
- Volume 18, 2023 (251)
- Volume 17, 2022 (253)
- Volume 16, 2021 (311)
- Volume 15, 2020 (325)
- Volume 14, 2019 (296)
- Volume 13, 2018 (397)
- Volume 12, 2017 (364)
- Volume 11, 2016 (343)
- Volume 10, 2015 (274)
- Volume 9, 2014 (134)
- Volume 8, 2013 (76)
- Volume 7, 2012 (84)
- Volume 6, 2011 (74)
- Volume 5, 2010 (49)
- Volume 4, 2009 (43)
- Volume 3, 2008 (83)
- Volume 2, 2007 (74)
- Volume 1, 2006 (54)
Journal Articles:
- Sarcopenia and frailty in COPD: Mechanisms, Biomarkers, and Potential Interventions (1)
- Promoting Optimized Health Care for Individuals with COPD in the Era of Telehealth (4)
- Precision Medicine in COPD (6)
- Epidemiology, Etiology, and Demography of COPD: Who, When, and How? (5)
- Personalizing self-management interventions in COPD – Tailoring towards individual preferences, needs, competences, disease characteristics and comorbidities (14)
- Cardiovascular disease and COPD (10)
- Psychological distress in COPD – prevalence, impact and management (4)
- Cardiac Safety Tiotropium and Olodaterol (4)
- Volume 11 - 1st World Lung Disease Summit (4)
- Continuing to Confront COPD (3)
Precision Medicine in COPD
Precision Medicine in cancer patients refers to a method of analyzing the genes of cancer cells using a next-generation sequencer, finding the gene mutation that caused the cancer, and using a molecularly targeted drug designed to be effective against that gene mutation. This is also called tailormade or personalized medicine. A definition of Precise Medicine in COPD does not yet exist. This Article Collection is a first step towards a definition.
Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease
Giraldo-Montoya ÁM, Torres-Duque CA, Giraldo-Cadavid LF, Laucho-Contreras ME, González-Flórez A, Santos AM, Tuta-Quintero EA, Celli BR, González-García M
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1-10
Published Date: 30 December 2023
Analysis of Key Genes and miRNA-mRNA Networks Associated with Glucocorticoids Treatment in Chronic Obstructive Pulmonary Disease
Wu JJ, Zhang PA, Chen MZ, Zhang Y, Du WS, Li XN, Ji GC, Jiang LD, Jiao Y, Li X
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:589-605
Published Date: 28 February 2024
Common Pathogeneses Underlying Asthma and Chronic Obstructive Pulmonary Disease -Insights from Genetic Studies
Hizawa N
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:633-642
Published Date: 4 March 2024
Symptom Burden of Patients with Chronic Obstructive Pulmonary Disease Attending the Westmead Breathlessness Service: Prevalence, Associations, and Sex-Related Differences
Roberts M, Smith T, Wheatley J, Cho JG
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2825-2837
Published Date: 30 November 2023
Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?
Nishimura K, Kusunose M, Shibayama A, Nakayasu K
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2955-2960
Published Date: 11 December 2023
Identification of Genes Related to Endoplasmic Reticulum Stress (ERS) in Chronic Obstructive Pulmonary Disease (COPD) and Clinical Validation
Tao S, Jing J, Wang Y, Li F, Ma H
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:3085-3097
Published Date: 27 December 2023